Outcomes of patients with metastatic renal cell carcinoma that do not meet eligibility criteria for clinical trials. (Record no. 23384766)

MARC details
000 -LEADER
fixed length control field 02387 a2200685 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250516185702.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201408s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1569-8041
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1093/annonc/mdt492
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Heng, D Y C
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20140811
245 00 - TITLE STATEMENT
Title Outcomes of patients with metastatic renal cell carcinoma that do not meet eligibility criteria for clinical trials.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Annals of oncology : official journal of the European Society for Medical Oncology
Date of publication, distribution, etc. Jan 2014
300 ## - PHYSICAL DESCRIPTION
Extent 149-54 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Monoclonal, Humanized
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Combined Chemotherapy Protocols
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Bevacizumab
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Brain Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Carcinoma, Renal Cell
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Clinical Trials as Topic
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Disease-Free Survival
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Eligibility Determination
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Indazoles
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Indoles
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Kaplan-Meier Estimate
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Karnofsky Performance Status
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Kidney Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Molecular Targeted Therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Niacinamide
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Phenylurea Compounds
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pyrimidines
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pyrroles
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Sorafenib
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Sulfonamides
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Sunitinib
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Choueiri, T K
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Rini, B I
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lee, J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Yuasa, T
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Pal, S K
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Srinivas, S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Bjarnason, G A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Knox, J J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Mackenzie, M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Vaishampayan, U N
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Tan, M H
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Rha, S Y
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Donskov, F
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Agarwal, N
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kollmannsberger, C
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name North, S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Wood, L A
773 0# - HOST ITEM ENTRY
Title Annals of oncology : official journal of the European Society for Medical Oncology
Related parts vol. 25
-- no. 1
-- p. 149-54
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1093/annonc/mdt492">https://doi.org/10.1093/annonc/mdt492</a>
Public note Available from publisher's website

No items available.